Although dysregulation of tight junction (TJ) proteins is observed in epithelial malignancy, their participation in epithelial transformation is poorly understood. Recently we demonstrated that expression of oncogenic Raf 1 in Pa4 epithelial cells disrupts TJs and induces an oncogenic phenotype by downregulating expression of the TJ protein, occludin. Here we report the mechanism by which Raf 1 regulates occludin expression. Raf 1 inhibited occludin transcription by repressing a minimal segment of the occludin promoter in concert with upregulation of the transcriptional repressor, Slug without influencing the well-documented transcriptional repressor, Snail. Overexpression of Slug in Pa4 cells recapitulated the effect of Raf 1 on occludin expression, and depletion of Slug by small interfering RNA abrogated the effect of Raf 1 on occludin. Finally, chromatin immunoprecipitation assays and site-directed mutagenesis demonstrated a direct interaction between Slug and an E-box within the minimal Raf 1-responsive segment of the occludin promoter. These findings support a role of Slug in mediating Raf 1-induced transcriptional repression of occludin and subsequent epithelial to mesenchymal transition.
Introduction
Regulation of cell-cell adhesion is critical for cell differentiation, tissue development and tissue homeostasis. Epithelial cell-cell adhesion is mediated through a series of intercellular junctions referred to as adherens junctions (AJs), tight junctions (TJs) and desmosomes. TJs are the most apical cell-cell contacts, forming the primary barrier to solute diffusion through the paracellular pathway and providing the boundary between the apical and basolateral plasma membrane domains characteristic of polarized epithelia (Furuse et al., 1994; Balda et al., 1996; Matter et al., 2005) . In addition, TJs separate discrete signal-transduction pathways of the intracellular and extracellular environments (Matter and Balda, 2003; Matter et al., 2005) . Downregulation of TJ proteins has profound effects on epithelial structure and has been observed in many human epithelial cancers (Hoover et al., 1998; Dhawan et al., 2005) .
TJ protein complex consists of a combination of transmembrane, scaffolding and regulatory proteins that influence cell polarity, growth and differentiation (Gonzalez-Mariscal et al., 2003) . Major families of transmembrane proteins include: occludin, claudins and JAM. The TJ protein, occludin was first identified and characterized as an integral membrane protein localized at TJ strands in chickens (Furuse et al., 1993 (Furuse et al., , 1994 and then in various mammalian species (Ando-Akatsuka et al., 1996) and was shown to be involved in epithelial barrier regulation and cell adhesion (Balda et al., 1996; McCarthy et al., 1996; Van Itallie and Anderson, 1997; Matter and Balda, 1998) .
Tumor cells, particularly in those cancers that manifest high metastatic potential, often exhibit loss of TJs. Downregulation of specific TJ proteins has been shown to correlate with staging, invasiveness and metastatic potential of epithelial cancers (Hoover et al., 1998; Tobioka et al., 2004b; Dhawan et al., 2005) . For example, levels of zonula occludens 1 (ZO-1), ZO-2, and occludin are decreased during tumor development and metastasis (Hoover et al., 1998; Kominsky et al., 2003) . In endometrial cancers, downregulation of occludin was shown to correlate with tumor grade, invasiveness and metastasis (Tobioka et al., 2004a, b) . Furthermore decreased expression of occludin was also observed in poorly differentiated gastrointestinal adenocarcinomas (Kimura et al., 1997) . Studies from our laboratory and others have suggested that Raf 1 overexpression causes loss of intercellular junctions, loss of the epithelial phenotype and acquisition of an invasive phenotype (Lehmann et al., 2000; Li and Mrsny, 2000; Lan et al., 2004) . Interestingly, forced expression of exogenous occludin rescued Raf 1-transformed cells from the tumorigenic phenotype thereby reverting them to their original epithelial organization with development of functional intercellular junctions and anchorage-dependent growth (Li and Mrsny, 2000; Wang et al., 2005) . Thus occludin appears to play an important role in stabilizing intercellular associations and suppressing tumor development in epithelial tissues. The molecular mechanisms by which Raf 1 suppresses occludin expression have however, not been defined and are the focus of this study. Our results suggest that Raf 1 induces upregulation of a transcriptional repressor, Slug that induces downregulation of occludin thereby contributing to the Raf 1-induced oncogenic transformation.
Results

Raf 1 represses occludin expression by inhibiting occludin promoter activity
We have previously reported that overexpression of the oncogene Raf 1 induced changes in epithelial cell morphology and downregulation of the TJ protein occludin (Li and Mrsny, 2000; Wang et al., 2005) , producing dramatic changes in cell morphology ( Figure 1a) . Raf 1-transformed Pa4 cells adopted a disorganized fibroblast-like appearance versus the parental Pa4 cells, which formed well-organized clusters of polarized epithelia (Figure 1a) . Furthermore, Raf 1-induced transformation of Pa4 epithelial cells induced downregulation of the occludin protein expression and loss of intercellular contacts (Figure 1b and c) . Although the Raf 1-transformed cells continue to express substantial amounts of ZO-1, Claudin-1 and E-cadherin (Figure 1b and c) , the distribution patterns of these proteins were completely disrupted (Li and Mrsny, 2000; Wang et al., 2005) . This result is consistent with our published data showing that Raf 1 represses expression of occludin in epithelial TJs, and this loss of occludin is associated with dramatic changes in cell growth and morphology (Li and Mrsny, 2000; Wang et al., 2005) . Experiments were therefore performed to elucidate the mechanisms by which Raf 1 affects occludin expression.
To investigate whether Raf 1 affects occludin expression at the messenger RNA (mRNA) level, semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was performed with mRNA samples from Raf 1-transformed Pa4 cells and compared to the parental Pa4 cell line. Occludin mRNA levels , but not that of Claudin-1, E-cadherin or ZO-1, were dramatically decreased in Pa4-Raf 1 cells relative to Pa4 cells (Figure 1d ). These findings suggest that Raf 1 induces transcriptional downregulatin of occludin. To determine whether this effect involves regulation of occludin promoter activity, a luciferase reporter construct containing the occludin promoter was trasfected into Pa4 cells and Raf 1-transformed Pa4 cells. As shown in Figure 2 , occludin promoter activity was inhibited almost completely in Pa4-Raf 1 cells as compared to the parental Pa4 line. These findings suggest that Raf 1 inhibits occludin mRNA expression by decreasing activity of the occludin promoter.
Identification of the minimal occludin promoter
To define elements within the human occludin promoter that are required for its activity, a series of promoter deletion constructs were prepared ( Figure 3a ) and transiently transfected into Pa4 cells. Progressive deletions from the 5 0 -end had minimal impact on promoter activity, and the fragment (À60 to þ 240) produced an activity comparable with the largest fragments (À1511 to þ 342) in Pa4 cells. Further deletions of this fragment, however, greatly affected promoter activity (Figure 3a) . Therefore, the sequence À60 þ 240 was identified as the minimal occludin promoter.
Sequence analysis of the minimal occludin promoter fragment (À60 þ 240) revealed that this fragment contains the putative transcription start point for the occludin mRNA and a number of transcription factor binding sites, including those for the transcriptional repressor proteins, Snail and Slug (E-box, 5 0 -CAGGTG) (Nieto, 2002) . To further confirm the observation that Raf 1 suppresses occludin promoter activity, we cotransfected Pa4 cells with the minimal occludin promoterluciferase reporter construct and constitutively active Raf 1. As shown in Figure 3b , in the absence of Raf 1, the activity of minimal occludin promoter (À60 þ 240) was comparable to that of the full-length promoter. In cells cotransfected with the Raf 1 oncogene, significant inhibition of the minimal occludin promoter activity was observed, and this inhibition was comparable to that of the full-length occludin promoter (Figure 3b ). These results suggest that the minimal occludin promoter fragment (À60 þ 240) contains the elements necessary for regulation by Raf 1.
Raf 1-mediated repression of occludin is blocked by inhibitors of the MAP kinase pathway Several studies have shown that Raf 1-induced oncogenic transformation and suppression of junctional protein expression depends on activation of the mitogen-activated protein kinase (MAPK) pathway (Chen et al., 2000) . To determine whether the MAPK pathway is involved in Raf 1-mediated suppression of occludin promoter activity, Pa4-Raf 1 cells were transfected with the occludin promoter luciferase reporter and incubated Progressive deletions were made within the full-length OccP, and their effect on promoter activity was measured using a luciferase reporter assay. The bar graph depicts normalized (to RLuc) luciferase activity for each deletion construct. As shown, the minimal region required for promoter activity was determined to be À60 to þ 240. (b) The full-length OccP and occludin minimal promoter (OccP min ) luciferase reporter constructs were transfected into Pa4 cells together with Raf 1 expression vector or control empty vector. Activities of the fulllength and minimal OccPs were analysed using a luciferase reporter assay. As shown, the inhibitory effect of Raf 1 on the minimal occludin promoter was comparable to its inhibitory effect on the full-length occludin promoter. Each bar on the graph represents the mean of three independent experiments; error bars indicate mean7s.d. of three experiments. . Together these results demonstrate that Raf 1-mediated inhibition of occludin promoter activity can be prevented by inhibition of the MAPK pathway.
Slug, but not Snail, is upregulated in Raf 1-transformed Pa4 cells Sequence analysis of the minimal occludin promoter fragment (À60 þ 240) revealed putative-binding sites for the zinc-finger transcription factors Snail and Slug (E-BOX, 5 0 -CAGGTG). Furthermore, previous studies have suggested that the transcription factors Snail and Slug can induce epithelial to mesenchymal transition (EMT), regulate cell-cell junction formation, and repress expression of the AJ protein, E-cadherin (Nieto, 2002; Kurrey et al., 2005) . Therefore, we sought to investigate whether Snail or Slug expression was affected by expression of Raf 1 in Pa4 cells. Whole-cell lysates from Pa4 and Pa4-Raf 1 cell lines were prepared and Slug and Snail proteins were detected by immunoblotting. Slug protein levels in Pa4-Raf 1 cells were significantly increased compared with parental Pa4 cells, whereas Snail protein levels were not significantly changed ( Figure 5a ). To determine whether or not Raf 1 affects Slug or Snail mRNA levels, total RNA from Pa4 and Pa4-Raf 1 cells was analysed by RT-PCR. Slug mRNA levels were markedly increased in Pa4-Raf 1 cells, whereas Snail mRNA levels were not affected by Raf 1 expression (Figure 5b ). To examine whether the effect of Raf 1 on Slug was dependent on the MAPK pathway, Pa4-Raf 1 cells were treated with the inhibitor U0126. Treatment of Pa4-Raf 1 cells with U0126 significantly reduced Slug protein and mRNA levels (Figure 5a and b) . No effect on Snail protein or mRNA levels was seen with the MAPK inhibitor U0126 (Figure 5a and b) . Overall, these results suggest that Raf 1 specifically induces expression of the transcription factor Slug, and induction of Slug expression by Raf 1 can be blocked by inhibition of the MAPK pathway.
The transcription factor Slug represses expression of occludin Having observed that Raf 1 expression resulted in increased expression of the zinc-finger transcription factor Slug, we sought to investigate whether forced expression of Slug in Pa4 cells would recapitulate the effects of Raf 1 on occludin expression. Pa4 cells were transiently transfected with constructs encoding enhanced green fluorescent protein (EGFP)-tagged Slug protein or EGFP alone. Cultures were then analysed by immunofluorescence confocal microscopy. Cells expressing Slug (Green) demonstrated loss of occludin at cellcell junctions. In contrast neighboring, untransfected Pa4 cells demonstrated ample occludin expression at cell junctions with a 'chicken wire' pattern typical of epithelial cells (Figure 6a ). These findings suggest that Slug expression results in loss of occludin at cell-cell junctions. Additionally, immunoblots showed a dramatic decrease in occludin protein expression in Slugtrasfected Pa4 cells as compared to the mock-transfected Figure 4 Blockade of the MAPK pathway rescues occludin promoter activity from inhibition by Raf 1. Pa4-Raf 1 cells were transfected with the occludin promoter luciferase reporter, and treated with either the MAPK inhibitor U0126, the PI3 kinase inhibitor LY294002 (LY) or no inhibitor at all (MOCK). The occludin promoter luciferase reporter-transfected Pa4 cells were shown for comparison. Occludin promoter activity was measured by luciferase reporter assay (top panel). MAPK activity was assessed by detecting pERK levels by Western blot (bottom panel). As shown, treatment of Raf 1-transformed Pa4 cells with the MAPK inhibitor U0126 blocked ERK phosphorylation and completely rescued activity of the occludin promoter. In contrast, the PI3 kinase inhibitor LY294002 did not affect pERK levels or occludin promoter activity. Having observed that Raf 1 stimulates expression of Slug ( Figure 5 ) and that overexpression of Slug represses occludin expression (Figure 6 ), experiments were performed to determine whether depletion of endogenous Slug from Raf 1-transformed cells rescues the epithelial phenotype. Specifically, an RNA interference-based approach was employed to examine whether knockdown of Slug by small interfering RNA (siRNA) affects epithelial morphology and occludin expression. Subconfluent Pa4-Raf 1 cell cultures were transfected with siRNA directed against Slug or control siRNA, and these cultures were compared to the parental Pa4 cell line. As illustrated in the phase-contrast images in Figure 7a (Figure 7c ). These results suggest that Slug is required for Raf 1-mediated inhibition of occludin expression. Furthermore, these findings are consistent with the observation that Raf 1 induces expression of Slug ( Figure 5 ) and that overexpression of Slug recapitulates the effects of Raf 1 on occludin (Figure 6 ).
Slug interacts with the occludin promoter via the E-boxbinding site The Slug overexpression and depletion experiments support the conclusion that Slug protein has the ability to repress the endogenous occludin promoter in rat cells. As the reporter gene assays were performed with human occludin sequences, we compared the DNA sequence of the putative occludin promoter from multiple species (Supplementary Figure 1) . The alignment revealed striking sequence conservation within the region defined as the minimal Raf 1 responsive element in this work. Of particular interest was the absolute conservation of the E-box sequence in all mammalian species examined. Given this evolutionary conservation, we sought to investigate whether the transcription factor Slug directly interacts with the rat occludin promoter in the vicinity of this conserved E-box sequence. Chromatin immunoprecipitation (ChIP) was performed using an antibody to Slug with chromatin fragments obtained from Pa4 and Pa4-Raf 1 cells. DNA coprecipitating with Slug was detected by quantitative PCR assay. PCR primers were specifically designed to amplify occludin promoter DNA sequence. The PCR amplicon specifically amplifies occludin promoter DNA including the conserved Ebox sequence (see Materials and methods for details on primer sites). As shown in Figure 8a , the anti-Slug antibody coprecipitated substantially more occludin promoter DNA than the nonspecific antibody controls, indicating a significant association of Slug with the occludin promoter. Further, this coprecipitation of occludin promoter DNA with Slug was substantially higher in the Pa4-Raf1 cell line than in the parental Pa4 cells. We concluded from this experiment that endogenous Slug directly associates with the rat occludin promoter DNA and that this association is promoted by the presence of an oncogenic form of Raf 1.
We next examined the impact of the conserved E-box on transcriptional repression in reporter gene assays. A mutation within the E-box of an occludin promoterluciferase reporter construct did not appear to affect occludin promoter activity in Pa4 cells (Figure 8b ). In Raf 1-and Slug-transfected cells, however, mutation of the E-box significantly increased occludin promoter activity as compared to the wild type E-box sequence (Figure 8b ). This finding suggests that the E-box sequence is critical for Raf 1/Slug-mediated repression of occludin promoter activity. Furthermore, these findings provide new findings supporting a role of Raf 1 in oncogenic transformation of epithelial cells via repression of the TJ protein, occludin.
Discussion
Events commonly associated with the oncogenic transformation of epithelial cells include the loss of cell-cell contacts and the acquisition of more migratory and invasive phenotypes (Birchmeier et al., 1993k) . Loss of AJ function has been shown to occur in epithelialderived cancers (Bulkholm et al., 1998k; Ruch et al., 1998k) . However, the impact of TJ function on oncogenic transformation of epithelial cells has not been clearly established. Using a rat salivary gland epithelial cell line, Pa4 we have previously reported that constitutive expression of Raf 1-induced downregulation of the TJ protein, occluding in addition to influencing distribution of other TJ and AJ proteins (Li and Mrsny, 2000; Wang et al., 2005) . In these studies internalization of claudin-1, ZO-1 and E-cadherin from the cell surface plasma membrane was associated with a biochemical shift of these proteins from Trition-X 100 insoluble into a soluble fraction. Introduction of exogenous occludin into such Raf 1-transformed cells was sufficient in inducing assembly of the TJs, rescue of the epithelial morphology and inhibition of their oncogenic phenotype. These findings provide new mechanistic evidence supporting the role of Raf 1 in oncogenic transformation of epithelial cells via repression of the TJ protein, occludin.
Our present study elucidates a mechanism by which Raf 1 affects occludin expression. We demonstrate that oncogenic Raf 1 suppresses activity of the occludin promoter by activating the zinc-finger transcription factor Slug in Pa4 epithelial cells. These studies show that Slug is a regulatory target of the Raf 1-induced oncogenic transformation of Pa4 epithelial cells. Although the mechanisms involved in regulation of TJ function have been extensively examined, promoter analyses of TJ proteins is only just beginning. In this report, we have analysed the human occludin promoter region (À1511/ þ 342) and examined its regulation by oncogenic Raf 1. We demonstrate that this occludin promoter fragment is regulated by Raf 1 activity. Deletion analysis revealed that a minimal active fragment (À60/240) exhibited comparable activity to the larger occludin promoter fragment (À1511/ þ 342) in Figure 8 Slug regulates occludin promoter activity by binding to the E-box domain. (a) ChIP was performed as described in Materials and methods. Amplification of rat genomic DNA was performed following immunoprecipitation with either a Slug antibody or a control (goat IgG) antibody. The graph depicts the mean and s.d. of three independent amplification reactions from a representative biological sample. (b) A mutation was made within in the E-box region of the occludin promoter, and Pa4 cells were transfected with occludin promoter-luciferase reporter constructs containing either the wild type or mutant E-box. In addition, these reporter constructs were cotransfected with vectors encoding either Slug or Raf 1. As shown, the E-box mutation was observed to rescue occludin promoter activity in cells expressing Raf 1 and Slug.
Slug mediates Raf 1-induced repression of occludin Z Wang et al Pa4 cells. Sequence analysis revealed that this minimal promoter contains the putative transcription start point for occludin mRNA, and a number of transcription factor binding sites, such as Snail/Slug-binding sites (E-BOX, 5
0 -CAGGTG). Our studies suggest that Raf 1 can suppress the minimal occludin promoter activity (À60 þ 240) and that mutation of the E-box putative Slug-binding sites within this promoter region impaired Raf 1-mediated repression occludin expression. Although a number of studies (Li and Mrsny, 2000; Lan et al., 2004) have reported that Raf 1 downregulates occludin expression and induces EMT, to our knowledge, the data presented here is the first report showing that oncogenic Raf 1 modulates occludin expression by influencing the E-box of the occludin promoter. The observation that the cis-acting regulatory sequences identified in the human occludin promoter are conserved across various mammalian species implies that the regulatory pathway identified here is also conserved.
Both oncogenic Raf 1 signaling pathway and the zincfinger transcription factor Slug have been reported to induce EMT and tumor cell metastasis; each being associated with loss of intercellular junctions, altered epithelial phenotype and acquisition of an invasive potential (Nieto, 2002; Nottage and Siu, 2002; Wellbrock et al., 2004; Perez-Mancera et al., 2005) . However, an interrelationship of the Raf 1 signaling pathway, Slug and EMT has not been reported. Our results in Pa4 epithelial cells suggest that oncogenic Raf 1 induces EMT by regulating expression of Slug, which in turn inhibits occludin expression. In this model system, oncogenic Raf 1 upregulates expression of Slug without influencing expression of a closely related zinc-finger transcription factor, Snail. The Snail family of zincfinger transcription factors, including Snail and Slug, play an important role in developmental processes such as gastrulation and mesoderm formation and are involved in a broad spectrum of biological functions, such as cell differentiation, cell motility, cell-cycle regulation and apoptosis (Batlle et al., 2000; Cano et al., 2000; Kurrey et al., 2005) . These proteins share a highly conserved C2H2-type zinc-finger domain, that binds to the E-box and repress transcription of target genes. More recently, Snail and Slug have been shown to function as potential regulators of cell adhesion and induce EMT (Nieto, 2002; Kang and Massague, 2004; Perez-Mancera et al., 2005) . In our study Raf 1-induced differential upregulation of Slug in Pa4 cells without influencing expression of Snail. Results of this nature support the idea that regulation of specific transcriptional factors in the Snail family can occur in different cell types.
MAPK signaling pathways have been implicated in the progression of human tumors via regulation of E-cadherin (Locascio et al., 2002; Barbera et al., 2004; Kajita et al., 2004) However, limited information is available regarding signaling pathways that govern expression of Snail or Slug proteins. Kinase activities of the MAPK pathway have been shown to regulate numerous transcriptional factors such as Ets, activator protein-1, nuclear factor-kappa B, c-Myc. Interestingly, a recent study has reported activation of the Snail promoter by the MAPK signaling pathway (Barbera et al., 2004) . In contrast to Snail, mechanisms governing the expression of Slug in mammalian cells are largely unknown. Our study suggests that Slug suppresses occludin and the associated Raf 1-induced EMT. A more complete understanding of the role of Slug and the MAPK signaling pathway in epithelial oncogenesis and physiologic processes such as epithelia wound repair will require additional studies. Our current findings however establish a mechanistic link between Raf 1 signaling, expression of Slug and occludin in the regulation of EMT.
Materials and methods
Reagents and antibodies
An antibody that specifically recognizes the phosphorylated form of ERK1 and ERK2 was obtained from Santa Cruz Biotechnologies Inc., Santa Cruz, CA, USA. Other antibodies included the following: rabbit anti-occludin, mouse antioccludin, mouse anti-ZO-1 (Zymed Laboratories Inc., South San Francisco, CA, USA), mouse anti-E-cadherin (BD Biosciences, San Jose, CA, USA), goat anti-Slug and goat anti-Snail (Santa Cruz Biotechnology Inc.). Horseradish peroxidase-conjugated secondary antibodies were obtained from Jackson ImmunoResearch, and fluorescently labeled secondary antibodies were obtained from Molecular Probes, Eugene, OR, USA. The inhibitors PD98059, U0126 and LY294002 were purchased from Calbiochem, San Diego, CA, USA. Rhodamine-phalloidin was obtained from Molecular Probes Inc.
Constructs and plasmids
A constitutively active Raf 1, comprised of the catalytic domain of human Raf 1 fused with the hormone-binding domain of human estrogen receptor was constructed as described previously (Li and Mrsny, 2000) . The plasmid encoding Raf BXB (a constitutively active form of Raf 1 containing only the catalytic domain of the kinase) and plasmid encoding RafC4B (a dominant-negative Raf 1 construct) were generated (Bruder et al., 1992) . The plasmid encoding human Slug was gift from Dr M Kajita. PCR amplified Slug open-reading frame (ORF) was subcloned to pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) and pEGFP-N3 (Clontech, Terra Bella Avenue Mountain View, CA, USA) expression vectors.
Occludin promoter deletion and mutant constructs
The human occludin-specific genomic DNA sequences, a 1853 bp DNA fragment containing -1511 to þ 342 bp from the transcription start site, were obtained from Dr JD Mankertz (Freie University Berlin,Germany). Subsequent deletion constructs of this fragment in front of the luciferase reporter gene were generated by PCR-based mutagenesis. PCR amplifications were performed with PFU DNA polymerase. Products were subcloned into the pCR-Blunt II-TOPO vector, confirmed by sequence analysis, and then cloned into the pGL3-basic vector (Promega, Madison, WI, USA). The occludin promoter E-box sequence 5 0 -CAGGTG, the putative transcription factor Slug/Snail-binding sites, were mutated to 5 0 -CTTCAG. The mutant was constructed using the Quickchange site-directed mutagenesis kit (Stratagene, La Jolla, CA, Cell culture, transfections and treatments Pa4 cells are an immortalized epithelial cell line derived from rat parotid gland. The Pa4-Raf 1 cells were generated by stably transfecting Pa4 cells with a constitutively active Raf 1 expression vector (Li and Mrsny, 2000) . Pa4 cells were cultured in Dulbecco's modified Eagle's (DMEM)/F12 (1:1) medium supplemented with 2.5% fetal bovine serum (FBS), insulin (5 mg/ml), transferrin (5 mg/ml), epidermal growth factor (25 ng/ml), hydrocortisone (1.1 mM) and glutamate (5 mM), and were maintained in a humidified atmosphere containing 5% CO 2 and 95% air at 351C. Pa4-Raf 1 cells were maintained in DMEM/F12 (1:1, phenol red-free) medium supplemented with 2.5% charcoal-stripped FBS, G418 (600 mg/ml) plus the above-mentioned factors. Cells transfections were carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
SiRNA knockdown experiments
SiRNA duplexes were designed in the Slug ORF based on standard design parameters involving target length, molar percentage of guanine and cytosine base content, and melting temperature. A basic local alignment search tool search was performed to ensure that the Slug siRNA target sequence did not cross-react with other known Rat genes. Custom chemically synthesized duplex siRNA against Slug was obtained from Invitrogen. In addition, validated control siRNA against Lamin A/C was obtained from Dharmacon. All of the siRNA transfections were performed using Lipofectamine 2000 (Invitrogen) in Opti-minimal essential medium I medium (Invitrogen) according to the manufacturer's protocol with a final siRNA concentration of 40 nM. Target sequence was: Slug siRNA1 (5 0 -ACCUCAGGAGC GUACAGCCCUAUAA-3 0 ).
Immunofluorescence labeling and confocal microscopy Epithelial cells grown on transwell filters or glass coverslips were rinsed twice with ice-cold 10 mM N-2-hydroxylpiperazine-N 0 -2-ethanesulfonic acid-buffered Hank's balanced salt solution (HBSS), pH 7.4. Cells were fixed/permeabilized in absolute ethanol for 20 min at À201C followed by blocking in HBSS containing 1% bovine serum albumin (blocking buffer) for 60 min at room temperature. The primary antibodies were diluted in blocking buffer and incubated with cells for 1 h at room temperature. The cells were washed twice in HBSS þ and then incubated with fluorescently labeled secondary antibodies for 1 h at room temperature. The cells were washed twice with HBSS þ and mounted in Prolong Antifade Agent (Molecular Probes). Cells were analysed using a Zeiss LSM510 laser scanning confocal microscope (Zeiss Microimaging, Thornwood, NY, USA) coupled to a Zeiss Axioplan2e with Â 63 or Â 100 Pan-Apochromat oil lenses.
ChIP ChIP was performed as described (Fujita et al., 2003) . Briefly, cells were fixed with 1% formaldehyde in phosphate-buffered saline, sonicated to generate 300-3000 bp DNA fragments. Immunoprecipitations were carried out with goat anti-Slug (Santa Cruz) or with normal goat immunoglobulin (Ig)G (Santa Cruz). Precipitated DNA was washed and processed for quantitative PCR amplification to detect occludin Promoter region with the following specific primer set: forward 5 0 -CTGGCAGCAGAGCACAGTAG -3 0 , reverse 5 0 -AGAC CATTTTGGGTGTGCTC -3 0 .
Western blots
Cells were homogenized in a PhosphoSafe extraction buffer (EMD Biosciences, Madison, WI, USA) containing a proteinase inhibitor cocktail (1:100; Sigma-Aldrich, St Louis, MO, USA) and 1 mM phenylmethylsulfonyl fluoride. Protein concentrations were determined by Pierce bicinchoninic acid assay. Lysates were then immediately boiled in Laemmli sample buffer (BIO-RAD Laboratories, CA, USA). Sodiumdodecylsulfate-polyacrylamide gel electrophoresis and immunoblots were performed using standard methodology. Immunoblots were probed for actin to ensure equal protein loading.
RNA Extraction and semiquantitative RT-PCR
Total RNA was extracted using RNeasy Mini kit coupled with RNase-free DNase set (Qiagen, Valencia, CA, USA). Total RNA (3 mg) was used for synthesis of complementary DNAs with SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) by using random hexamers. The 2 ml of the resulting reaction product were used for PCR amplification in 50-ml-reaction volume using specific primers for Slug, Snail, E-cadherin, occludin, Claudin-1, ZO-1 and b-actin. b-actin served as an internal control in all reactions. Primer sequences are available on request.
